Retrospective Study
Copyright ©The Author(s) 2016.
World J Hepatol. Dec 8, 2016; 8(34): 1502-1510
Published online Dec 8, 2016. doi: 10.4254/wjh.v8.i34.1502
Table 3 Statistical analysis of prognostic factors with respect to overall survival
Demographic, clinical and pathological factorsSurvival [median (range) mo]Uni-variate analysisMulti-variate analysisRisk ratio (confidence interval)
Demographic factors
Age0.173
< 65 yr (n = 43)20 (6-48)
≥ 65 yr (n = 28)27 (7-48)
Gender0.0240.0363.172 (1.079-9.327)
Male (n = 50)19 (6-48)
Female (n = 21)20 (11-48)
Presentation0.932
Synchronous (n = 35)23 (6-48)
Metachronous (n = 36)24 (6-48)
Surgical factors
Less than hemi- hepatectomy (n = 49)22 (6-48)0.947
Hemi-hepatectomy or more (n = 22)28 (7-48)
Histo-pathological factor
Largest tumour size0.216
< 5 cm (n = 60)24 (6-48)
≥ 5 cm (n = 11)28 (12-48)
Number of metastases0.674
< 4 (n = 44)24 (6-48)
> 5 (n = 27)24 (11-48)
Lymphatic invasion0.943
Positive (n = 15)24 (11-48)
Negative (n = 56)23 (6-48)
Vascular invasion0.367
Positive (n = 28)25 (6-48)
Negative (n = 43)23 (6-48)
Peri-neural invasion0.220
Positive (n = 9)12 (11-48)
Negative (n = 62)24 (6-48)
Biliary invasion0.608
Positive (n = 25)27 (11-48)
Negative (n = 46)22 (6-48)
Resection margin (R0)0.0220.0300.403 (0.178-0.917)
R0 (n = 40)24 (6-48)
R1 (n = 31)22 (6-48)